HieFo Unveils HOT25 Specialty DFB Laser Chip to Power Next-Generation OTDR Systems GlobeNewswire July 30, 2025 ALHAMBRA, Calif., July 30, 2025 (GLOBE NEWSWIRE) — HieFo Corporation, a leader in InP-based optical chip innovation, today announced the commercial release of its new HOT25 Specialty Distributed Feedback (DFB) Laser Chip–engineered specifically for Optical Time Domain Reflectometer (OTDR) […]
Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy GlobeNewswire July 30, 2025 BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry,
SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation for Major Drill Program at the 100% Owned Radar Titanium Property in Labrador, Canada GlobeNewswire July 30, 2025 VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics GlobeNewswire July 30, 2025 • Allen Institute to employ Iterative Mapping, Nautilus' single-molecule proteomics method, to investigate connection between tau protein and Alzheimer's disease • Agreement links the organizations' next-generation proteomics technology and neuroscience leadership to potentially unlock breakthrough therapeutics
Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models GlobeNewswire July 30, 2025 -Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology Innovation Source (OIS) Retina 8th Annual Innovation Summit -VLTR-559, a long-acting anti-VEGF therapy, could reduce dosing frequency for the treatment
VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo GlobeNewswire July 30, 2025 Trial Did Not Meet Primary Endpoint or Key Secondary Endpoint of F-VASI50 and F-VASI75 Nominally Statistically Significant Effects Observed in Key Secondary and Exploratory Endpoints of Change from Baseline in F-VASI and T-VASI at 3% Concentration
Aventis Energy Announces Management Changes GlobeNewswire July 30, 2025 VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — Aventis Energy (“Aventis” or the “Company“) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce the appointment of Michael Mulberry, current Director of Aventis, as Chief Executive Officer and Corporate Secretary of the Company and the
PodcastOne (Nasdaq: PODC) Reports Preliminary Q1 FY 2026 Results, Record Revenue of ~$15M, Raises Guidance GlobeNewswire July 30, 2025 Q1 FY 2026 Record Revenue of ~$15M+ and Adj. EBITDA* of $580K (+284% YoY) Contribution Margin*: ~$2.4M or 16% Raises FY 2026 Guidance: $56-60M, Adjusted EBITDA*: $3-5M Added 14 new podcasts in Q1 FY 2026 (200+
Smith Comics Takes His Proven Educational Comic Book Series Into the Highly Competitive Animation Market GlobeNewswire July 30, 2025 WINTER GARDEN, Fla., July 30, 2025 (GLOBE NEWSWIRE) — The animation industry has just gained a proven heavyweight. A Media Snippet accompanying this announcement is available by clicking on this link. Robert J. Smith, MFA, a
Immutep Quarterly Activities Report Q4 FY25 GlobeNewswire July 30, 2025 Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countries Trial-in-Progress poster for TACTI-004 presented at the 2025 American Society